Theragnostics Ltd: Developing New Radiotherapies Targeted To PARP

Prostate Cancer Is One Of The Initial Targets For Theragnostics' Technology

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.